MBA501: Dynamic Strategy and Disruptive Innovation - Management Assignment

Internal Code: MAS3863

Management Assignment:

The company is governed by a board of seven directors that oversee the senior management team. The board of directors expect the senior management team to be vigilant and quick to spot potential new innovations in nuclear medicine but there is no systematic approach in place for the identification or creation of potentially disruptive technologies. The senior management team is made up of the heads of each of the company’s large departments including operations, finance, marketing, and research and development. The team meets regularly to review and debate the merits of new company projects which are assessed primarily on their potential to generate profit for the company. This has been a relatively successful approach so far and the company has been able to consistently pay increasing dividends to its shareholders who have developed an expectation of better than average returns as a result. Questions:   1) Internal perspective 2) External perspective 3) Marketing perspective 4) Technology perspective